Jump to content

ATC code A08

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Wknight94 (talk | contribs) at 02:14, 3 January 2009 (Cat index). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

ATC code A: Alimentary tract and metabolism
A01 Stomatological preparations A02 Drugs for acid related disorders A03 Drugs for functional gastrointestinal disorders A04 Antiemetics and antinauseants A05 Bile and liver therapy A06 Drugs for constipation A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents A08 Antiobesity preparations, excluding diet products A09 Digestives, including enzymes A10 Drugs used in diabetes A11 Vitamins A12 Mineral supplements A13 Tonics A14 Anabolic agents for systemic use A15 Appetite stimulants A16 Other alimentary tract and metabolism products
Other ATC codes
A B C D G H QI J L M N P R S V

A08 Antiobesity preparations, excluding diet products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System.

It is part of the anatomical group A Alimentary tract and metabolism.

A08A Antiobesity preparations, excluding diet products

A08AA Centrally acting antiobesity products

A08AA01 Phentermine

A08AA02 Fenfluramine

A08AA03 Amfepramone

A08AA04 Dexfenfluramine

A08AA05 Mazindol

A08AA06 Etilamfetamine

A08AA07 Cathine

A08AA08 Clobenzorex

A08AA09 Mefenorex

A08AA10 Sibutramine

A08AA56 Ephedrine, combinations

A08AB Peripherally acting antiobesity products

A08AB01 Orlistat

A08AX Other antiobesity drugs

A08AX01 Rimonabant

See also

Diet products are in the ATC group V06A.

Antiobesity agents/Anorectics (A08)

Amphetamines and phenethylamines	4-Methylamphetamine^‡ Amfecloral Amfepentorex Amfepramone Amphetamine Amphetaminil Benzphetamine Cathine Cathinone Chlorphentermine Clobenzorex Cloforex Clortermine Dextroamphetamine Dimethylcathinone Ephedrine Ephedra^‡ Etilamfetamine Etolorex Fenethylline Fenproporex Fludorex Furfenorex^‡ Khat Lisdexamfetamine Mefenorex Methamphetamine Norfenfluramine Pentorex Phentermine (+topiramate) Xylopropamine Zylofuramine
Adrenergic agonists	Albuterol Clenbuterol^§ Ephedrine Ephedra^‡ Levopropylhexedrine Synephrine Terbutaline Yohimbine (Yohimbe)
Other	Aminorex^‡ Atomoxetine Benfluorex^‡ Bupropion (+naltrexone) Dexfenfluramine^‡ Dexmethylphenidate Difemetorex^‡ Fenbutrazate Fenfluramine (+phentermine^‡) Manifaxine Mazindol Methylphenidate Phendimetrazine Phenethylamine Phenmetrazine Phenylpropanolamine Pipradrol Propylhexedrine Pyrovalerone Sibutramine^‡ Tesofensine

Cannabinoid
antagonists

GLP-1, GIP, and / or
glucagon agonists

Cagrilintide (+semaglutide^†)

5-HT2C
receptor agonists

5-HTP
Lorcaserin^‡

Absorption inhibitors

2,4-Dinitrophenol^‡

Others

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

Retrieved from "https://en.wikipedia.org/w/index.php?title=ATC_code_A08&oldid=261581968"

ATC codes